Sugimoto Yumi, Tagawa Noriko, Kobayashi Yoshiharu, Hotta Yoshihiro, Yamada Jun
Laboratory of Pharmacology, Department of Clinical Pharmacy, Yokohama College of Pharmacy, Matano-cho, Totsukaku, Yokohama 245-0066, Japan.
Biol Pharm Bull. 2007 Dec;30(12):2399-401. doi: 10.1248/bpb.30.2399.
The effects of milnacipran, a serotonin and noradrenaline reuptake inhibitor (SNRI) on the obsessive compulsive disorder (OCD) model, marble burying behavior, were investigated in mice. Milnacipran above the dosage of 10 mg/kg inhibited marble burying behavior significantly in mice as similar to fluvoxamine. Milnacipran inhibiting marble burying behavior did not affect locomotor activity. These results suggest that milnacipran can inhibit marble burying behavior and that milacipran may be useful for OCD therapy.
在小鼠中研究了5-羟色胺和去甲肾上腺素再摄取抑制剂(SNRI)米那普明对强迫症(OCD)模型——埋大理石行为的影响。剂量高于10mg/kg的米那普明与氟伏沙明类似,能显著抑制小鼠的埋大理石行为。米那普明抑制埋大理石行为但不影响运动活性。这些结果表明米那普明可抑制埋大理石行为,且米那普明可能对强迫症治疗有用。